Malarone Tablet, Film Coated
Product Images NDC 0173-0675

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Malarone (NDC 0173-0675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquone Molecular Structure (Malarone Spl Graphic 01)

Atovaquone Molecular Structure (Malarone Spl Graphic 01)
Chemical structure diagram showing a molecule containing chlorine, hydroxyl, and carbonyl functional groups. This is identified as the chemical structure of atovaquone, one of the active ingredients in MALARONE tablets.*
FDA Label Image

Proguanil Hydrochloride Molecular Structure (Malarone Spl Graphic 02)

Proguanil Hydrochloride Molecular Structure (Malarone Spl Graphic 02)
Chemical structure diagram of proguanil hydrochloride, one of the active ingredients in MALARONE (atovaquone and proguanil hydrochloride). The structure shows the molecular arrangement including the chlorine and hydrochloride components.*
FDA Label Image

Malarone Adult 100 Count Label (Malarone Spl Graphic 03)

Malarone Adult 100 Count Label (Malarone Spl Graphic 03)
MALARONE tablets film coated label showing active ingredients atovaquone 250 mg and proguanil HCl 100 mg. The label indicates a package size of 100 tablets, with storage instructions and safety warnings. The product is distributed by GlaxoSmithKline LLC and is made in Canada.*
FDA Label Image

Malarone Pediatric 100 Count Label (Malarone Spl Graphic 04)

Malarone Pediatric 100 Count Label (Malarone Spl Graphic 04)
MALARONE Pediatric Tablets label showing atovaquone and proguanil HCl with strengths of 62.5 mg atovaquone and 25 mg proguanil HCl per tablet. The film-coated oral tablet package contains 100 tablets. The label includes storage instructions and warnings, distributed by GlaxoSmithKline LLC, made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.